Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
274 studies found for:    "Diabetic Nephropathies"
Show Display Options
Download search resultsDownload the search results for:
"Diabetic Nephropathies" (274 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995 Low;   Drug: MT-3995 Middle;   Drug: MT-3995 High;   Drug: Placebo
2 Completed Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995-Low;   Drug: MT-3995-High;   Drug: Placebo
3 Completed Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995;   Drug: Placebo
4 Completed The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention:
5 Completed Spironolactone in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Spironolactone
6 Terminated Effect of Sulodexide in Overt Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Sulodexide
7 Completed Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN)
Condition: Diabetic Nephropathy
Intervention: Other: Multifactorial Intervention
8 Completed Evaluation Study for the Programme DiaNe for People With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Behavioral: DiaNe consultation and support program
9 Completed A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995 Low;   Drug: MT-3995 High;   Drug: Placebo
10 Completed A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995 Low;   Drug: MT-3995 High;   Drug: Placebo
11 Recruiting Resveratrol's Effects in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Resveratrol;   Drug: Placebo;   Drug: Losartan
12 Unknown  Colchicine for Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: colchicine
13 Completed Effect of Pyridorin in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Pyridorin (pyridoxamine dihydrochloride)
14 Completed Effect of Pyridorin in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Pyridorin (pyridoxamine dihydrochloride)
15 Completed Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: placebo;   Drug: Milk Thistle extract
16 Completed Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Sevelamer Carbonate;   Drug: Calcium Carbonate
17 Recruiting Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan
Condition: Type 2 Diabetic Nephropathy
Interventions: Drug: Alfacalcidol;   Drug: Irbesartan
18 Completed Benfotiamine in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Benfotiamine;   Drug: Placebo
19 Unknown  Aldosterone in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Spironolactone;   Drug: Placebo
20 Completed Effects of PH3 in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: PH3

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.